Literature DB >> 6093254

Growth inhibitor from BSC-1 cells closely related to platelet type beta transforming growth factor.

R F Tucker, G D Shipley, H L Moses, R W Holley.   

Abstract

Purified growth inhibitor from BSC-1 cells and type beta transforming growth factor from human platelets are shown to have nearly identical biological activity and to compete for binding to the same cell membrane receptor. These findings suggest that the growth inhibitor and the type beta transforming growth factor are similar molecules. The data also show that the same purified polypeptide can either stimulate or inhibit cell proliferation depending on the experimental conditions.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6093254     DOI: 10.1126/science.6093254

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  167 in total

1.  An antibody present in normal human serum inhibits the binding of cytokines to their receptors in an in vitro system.

Authors:  D E Mosedale; D J Grainger
Journal:  Biochem J       Date:  1999-10-01       Impact factor: 3.857

Review 2.  Role of cytokines in the pathogenesis of posterior capsule opacification.

Authors:  W R Meacock; D J Spalton; M R Stanford
Journal:  Br J Ophthalmol       Date:  2000-03       Impact factor: 4.638

3.  TGF-beta in mammary development and neoplasia.

Authors:  C L Arteaga; H L Moses
Journal:  J Mammary Gland Biol Neoplasia       Date:  1996-10       Impact factor: 2.673

4.  Functional proteomics of transforming growth factor-beta1-stimulated Mv1Lu epithelial cells: Rad51 as a target of TGFbeta1-dependent regulation of DNA repair.

Authors:  Takashi Kanamoto; Ulf Hellman; Carl-Henrik Heldin; Serhiy Souchelnytskyi
Journal:  EMBO J       Date:  2002-03-01       Impact factor: 11.598

Review 5.  Latent-TGF-beta: an overview.

Authors:  D A Lawrence
Journal:  Mol Cell Biochem       Date:  2001-03       Impact factor: 3.396

6.  A phorbol ester-regulated ribonuclease system controlling transforming growth factor beta 1 gene expression in hematopoietic cells.

Authors:  R E Wager; R K Assoian
Journal:  Mol Cell Biol       Date:  1990-11       Impact factor: 4.272

7.  Transforming growth factor beta 1 (TGF beta 1) reduces cellular levels of p34cdc2, and this effect is abrogated by adenovirus independently of the E1A-associated pRB binding activity.

Authors:  S E Abraham; M C Carter; E Moran
Journal:  Mol Biol Cell       Date:  1992-06       Impact factor: 4.138

8.  Transforming growth factor-ßs as modulators of pericellular proteolytic events.

Authors:  J Keski-Oja; J Lohi; M Laiho
Journal:  Cytotechnology       Date:  1989-12       Impact factor: 2.058

9.  The effects of type beta transforming growth factor on proliferation and epidermal growth factor receptor expression in a human glioblastoma cell line.

Authors:  E Helseth; G Unsgaard; A Dalen; R Vik
Journal:  J Neurooncol       Date:  1988-11       Impact factor: 4.130

10.  Correlation of fibrosis and transforming growth factor-beta type 2 levels in the eye.

Authors:  T B Connor; A B Roberts; M B Sporn; D Danielpour; L L Dart; R G Michels; S de Bustros; C Enger; H Kato; M Lansing
Journal:  J Clin Invest       Date:  1989-05       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.